Moreover, the expression of PD-L1 and IDO1 was higher in patients without alcohol and tobacco history, suggesting that patients with HNSCC that do not smoke or drink may benefit more from PD-L1 and IDO1 inhibition (108). The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.